FindTrial
Sign In

Clinical study on lymph node dissection of thymic tumors and its effect on prognosis

Clinical study on lymph node dissection of thymic tumors and its effect on prognosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000028816
Enrollment
Unknown
Registered
2020-01-04
Start date
2020-01-31
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thymic tumor

Interventions

1:1

Sponsors

Shanghai Chest Hospital, Shanghai Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: a)Preoperative imaging and intraoperative staging of T3-T4 thymic tumour; b) T1-T2 thymic tumor with B3 / Ca / NETT frozen during operation and advanced stage (UICC stage II-IV) judged by preoperative imaging; c) Tumour with surgical radical resection (R0 resection), The surgical approach is not limited to open or minimally invasive surgery, but tumour resection or thymectomhy must be done.

Exclusion criteria

Exclusion criteria: Patients with other malignant tumors, unless other malignant tumors have been cured.

Design outcomes

Primary

MeasureTime frame
Incidence of lymph nodal involvement;—

Secondary

MeasureTime frame
Safety and feasibility of lymph node dissection;—

Countries

China

Contacts

Public ContactWentao Fang

Shanghai Chest Hospital

vwtfang12@shchest.org+86 18017321389

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026